Benefits of a pediatric antimicrobial stewardship program at a children's hospital

Pediatrics

Volumn 128, Issue 6, 2011, Pages 1062-1070

  Di Pentima, M Cecilia ^a   Chan, Shannon ^b   Hossain, Jobayer ^c,d  

^a VANDERBILT UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c NEMOURS CHILDREN S CLINIC   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Antimicrobial stewardship program; Pediatrics

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; LINEZOLID; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; AUTOMATION; CHILD; DEMOGRAPHY; DRUG INDICATION; GRAM NEGATIVE BACTERIUM; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFECTION; INFORMATION SYSTEM; MEDICAL AUDIT; MICROBIOLOGY; PEDIATRIC ANTIMICROBIAL STEWARDSHIP PROGRAM; PEDIATRIC HOSPITAL; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 83155182579     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3589     Document Type: Article

References (34)

1. Spellberg B, Guidos R, Gilbert D, et al. Infectious Diseases Society of America. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155-164 (Pubitemid 351269151)
2. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1-12
3. Infectious Diseases Society of America. The 10 X '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis. 2010;50(8):1081-1083
4. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42(5):657-668 (Pubitemid 43271379)
5. Owens RC Jr, Shorr AF, Deschambeault AL. Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm. 2009;66(12 suppl 4):S15-S22
6. Fishman N. Antimicrobial stewardship. Am J Infect Control. 2006;34(5 suppl 1):S55-S63; discussion S64-S73
7. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177 (Pubitemid 46084814)
8. Paterson DL. The role of antimicrobial management programs in optimizing antibiotic prescribing within hospitals. Clin Infect Dis. 2006;42(suppl 2):S90-S95
9. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638-656 (Pubitemid 41504509)
10. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157(15):1689-1694 (Pubitemid 27327405)
11. Di Pentima MC, Chan S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J. 2010;29(8):707-711
12. Di Pentima MC, Chan S, Eppes SC, Klein JD. Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection and intervention. Clin Pediatr (Phila). 2009;48(5):505-512
13. Patel SJ, Larson EL, Kubin CJ, Saiman L. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26(6):531-537 (Pubitemid 46847316)
14. Girouard S, Levine G, Goodrich K, et al. Pediatric Prevention Network. Infection control programs at children's hospitals: a description of structures and processes. Am J Infect Control. 2001;29(3):145-151 (Pubitemid 32507078)
15. Agwu AL, Lee CK, Jain SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis. 2008;47(6):747-753
16. Hersh AL, Beekmann SE, Polgreen PM, Zaoutis TE, Newland JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30(12):1211-1217
17. Metjian TA, Prasad PA, Kogon A, Coffin SE, Zaoutis TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27(2):106-111
18. Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol. 2009;30(6):600-603
19. Pakyz AL, MacDougall C, Oinonen M, Polk RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med. 2008;168(20):2254-2260
20. Prasad PA, Coffin SE, Leckerman KH, Walsh TJ, Zaoutis TE. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J. 2008;27(12):1083-1088
21. de With K, Steib-Bauert M, Knoth H, et al. Hospital use of systemic antifungal drugs. BMC Clin Pharmacol. 2005;5(1):1
22. Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol. 1999;37(3):531-537 (Pubitemid 29091259)
23. Coulter M, Hossain J, Chan S, Di Pentima MC. Evolution of Gram-negative bacilli fluoroquinolone resistance in pediatric patients [abstr]. Presented at: 48th annual meeting of the Infectious Diseases Society of America; October 21-24, 2010; Vancouver, British Columbia, Canada
24. Di Pentima MC, Chan S. Impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital [abstr]. Presented at: 48th annual meeting of the Infectious Diseases Society of America; October 21-24, 2010; Vancouver, British Columbia, Canada
25. Barlam TF, DiVall M. Antibiotic-stewardship practices at top academic centers throughout the United States and at hospitals throughout Massachusetts. Infect Control Hosp Epidemiol. 2006;27(7):695-703 (Pubitemid 44271950)
26. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother. 2004;53(5):853-859 (Pubitemid 38660291)
27. Solomon DH, Van Houten L, Glynn R J, et al. Academic detailing to improve use of broadspectrum antibiotics at an academic medical center. Arch Intern Med. 2001;161(15):1897-1902 (Pubitemid 32762737)
28. Di Pentima MC, Chan S. Driving forces of vancomycin-resistant E. faecium [abstr]. Presented at: 46th annual meeting of the Infectious Diseases Society of America/48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; October 25-28, 2008; Washington, DC
29. Di Pentima MC, Chan S. Pediatric experience with Staphylococcus aureus MICs and vancomycin use: antimicrobial exposure and evolution [abstr]. Presented at: 47th annual meeting of the Infectious Diseases Society of America; October 29-November 1, 2009; Philadelphia, PA
30. Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53(5):1983-1986
31. Monnet DL. Measuring antimicrobial use: the way forward. Clin Infect Dis. 2007;44(5):671-673
32. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother. 2010;65(1):163-168
33. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44(5):664-670
34. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001;33(3):289-295 (Pubitemid 32664829)